Clinical Research Directory
Browse clinical research sites, groups, and studies.
5 clinical studies listed.
Filters:
Tundra lists 5 Omega-3 Fatty Acids clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.
This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.
NCT07677995
Free Fatty Acid Effects In Type 2 Diabetes
Omega-3 fatty acids are natural fats found in foods such as oily fish and flaxseed. Omega-3 fatty acids have been found to have positive effects on cardiovascular health, but there is less evidence on if they can help manage blood glucose in individuals with both cardiovascular disease and type 2 diabetes. This study will investigate whether the beneficial effects found in omega-3 fatty acids such as lowered blood glucose and reduced inflammation - both of which are important for managing type 2 diabetes and cardiovascular disease, can be beneficial for individuals with type 2 diabetes. As omega-3 fatty acids are already found naturally in food, and are already available as supplements, they could be a safe option to help manage these diseases. The aim of this study is to investigate if omega-3 fatty acids can slow down the progression of type 2 diabetes and reduce the risk of cardiovascular disease in individuals with type 2 diabetes.
Gender: All
Ages: 18 Years - Any
Updated: 2026-09-01
1 state
NCT07771309
Study of Metabolic Absorption Rates of DHA-Taurine as a Source of Omega-3 Fatty Acids
* Omega-3 fatty acids such as docosahexaenoic acid (DHA) have well-established health benefits and are widely used to improve cardiometabolic health. However, conventional DHA supplements require normal digestion and absorption of dietary fat, which may limit their effectiveness in individuals with impaired fat absorption or those consuming very low-fat diets. * This study investigates the absorption of a novel DHA-containing molecule, DHA-taurine (DHA-T), compared with a conventional DHA ethyl ester (DHA-EE) supplement. Preclinical studies suggest that DHA-T may be absorbed through a different mechanism that is less dependent on normal fat digestion and may therefore provide a more effective way of delivering DHA. * The primary objective is to compare plasma DHA concentrations following administration of DHA-T and DHA-EE under fasting conditions without a meal. The study also evaluates plasma DHA-T concentrations to improve understanding of the absorption, transport, and metabolism of DHA-T in humans. * This is a randomized, double-blind, crossover study in seven healthy male volunteers aged 18 to 30 years. Each participant receives both study interventions in random order, separated by an approximately two-week washout period, allowing each participant to serve as his own control. On each study day, participants undergo repeated blood sampling and ultrasound measurements of gallbladder volume over an 8-hour absorption test following administration of the assigned study intervention. * The results of this study will improve understanding of the absorption and metabolism of DHA-T and may support the future development of omega-3 formulations that are effective even when normal fat absorption is impaired.
Gender: MALE
Ages: 18 Years - 30 Years
Updated: 2026-08-18
NCT07665918
Evaluation of OMEGA-3 Effect in Alveolar Socket Preservation in Aesthetic Zone
To evaluate the effect of Omega-3 in preserving bone after extraction
Gender: All
Ages: 18 Years - Any
Updated: 2026-06-24
NCT06736925
Omega-3 Fatty Acids and Subconcussive Head Impacts
The purpose of the proposed double-blind, randomized placebo-controlled trial is to understand how supplementation with fish oil \[docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA)\] promote brain health against soccer heading. The study involves taking DHA+EPA or placebo, questionnaires, blood draws, brain imaging, tests to evaluate heart function, and soccer headings.
Gender: All
Ages: 18 Years - 30 Years
Updated: 2026-04-29
1 state
NCT07480707
Can People Achieve a Target Omega-3 Index by Following a Personalized Omega-3 Dosing Regimen?
The goal of this project is to evaluate the efficacy of personalized dosage recommendations of Parasol Omega-3 Fish Oil on achieving an Omega-3 Index of \>8% in individuals with a baseline Omega-3 Index \<8% over a 90-day period.
Gender: All
Ages: 18 Years - Any
Updated: 2026-03-18